Effects of the monoamine oxidase inhibitors pargyline and tranylcypromine on cellular proliferation in human prostate cancer cells

Oncology Reports

Volumn 30, Issue 4, 2013, Pages 1587-1592

  Lee, Hyung Tae ^a   Choi, Mi Ran ^a   Doh, Mi Sook ^a   Jung, Kyoung Hwa ^a   Chai, Young Gyu ^a  

^a Hanyang University   (South Korea)

Author keywords

Apoptosis; Cell cycle; Cellular proliferation; Pargyline; Prostate cancer cells

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; PARGYLINE; TRANYLCYPROMINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL SURVIVAL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOCHROMES C; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MALE; MONOAMINE OXIDASE INHIBITORS; PARGYLINE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TRANYLCYPROMINE;

EID: 84882700612     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2635     Document Type: Article

References (36)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Dunn MW and Kazer MW: Prostate cancer overview. Semin Oncol Nurs 27: 241-250, 2011.
3. McCloskey DE, Casero RA Jr, Woster PM and Davidson NE: Induction of programmed cell death in human breast cancer cells by an unsymmetrically alkylated polyamine analogue. Cancer Res 55: 3233-3236, 1995.
4. Huang Y, Hager ER, Phillips DL, et al: A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells. Clin Cancer Res 9: 2769-2777, 2003.
5. Zhang L and Webster TJ: Poly-lactic-glycolic-acid surface nanotopographies selectively decrease breast adenocarcinoma cell functions. Nanotechnology 23: 155101, 2012.
6. Mertens-Talcott SU, Noratto GD, Li X, Angel-Morales G, Bertoldi MC and Safe S: Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10. Mol Carcinog: Mar 7, 2012 (Epub ahead of print). doi: 10.1002/mc.21893.
7. Zhang X, Zhang S, Liu Y, et al: Effects of the combination of RAD001 and docetaxel on breast cancer stem cells. Eur J Cancer 48: 1581-1592, 2012.
8. Thapa D and Ghosh R: Antioxidants for prostate cancer chemoprevention: challenges and opportunities. Biochem Pharmacol 83: 1319-1330, 2012.
9. Kumar R, Verma V, Jain A, Jain RK, Maikhuri JP and Gupta G: Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer. J Nutr Biochem 22: 723-731, 2011.
10. Huang CH, Guh JH, Chen GS, Lu PH and Chern JW: Anticancer activity of a cyclooxygenase inhibitor, CX9051, in human prostate cancer cells: the roles of NF-κB and crosstalk between the extrinsic and intrinsic apoptotic pathways. Naunyn Schmiedebergs Arch Pharmacol 382: 159-169, 2010.
11. Lim S, Janzer A, Becker A, et al: Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31: 512-520, 2010.
12. Schmidt DM and McCafferty DG: trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. Biochemistry 46: 4408-4416, 2007.
13. Cortez V, Mann M, Tekmal S, et al: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer. Breast Cancer Res 14: R108, 2012.
14. Flamand V, Zhao H and Peehl DM: Targeting monoamine oxidase A in advanced prostate cancer. J Cancer Res Clin Oncol 136: 1761-1771, 2010.
15. Schulte JH, Lim S, Schramm A, et al: Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res 69: 2065-2071, 2009.
16. Lee HT, Jung KH, Kim SK, Choi MR and Chai YG: Effects of pargyline on cellular proliferation in human breast cancer cells. Mol Cell Toxicol 8: 393-399, 2012.
17. Lee HT, Kim SK, Choi MR, Park JH, Jung KH and Chai YG: Effects of the activated mitogen-activated protein kinase pathway via the c-ros receptor tyrosine kinase on the T47D breast cancer cell line following alcohol exposure. Oncol Rep 29: 868-874, 2013.
18. Baik SY, Jung KH, Choi MR, et al: Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells. Neurosci Lett 374: 53-57, 2005.
19. Choi MR, Oh DH, Kim SH, et al: Fluoxetine up-regulates Bcl-xL expression in rat C6 glioma cells. Psychiatry Investig 8: 161-168, 2011.
20. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
21. Pollock JA, Larrea MD, Jasper JS, McDonnell DP and McCafferty DG: Lysine-specific histone demethylase 1 inhibitors control breast cancer proliferation in ERα-dependent and -independent manners. ACS Chem Biol 7: 1221-1231, 2012.
22. Benelkebir H, Hodgkinson C, Duriez PJ, et al: Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors. Bioorg Med Chem 19: 3709-3716, 2011.
23. Kim SJ, Min HY, Lee EJ, et al: Growth inhibition and cell cycle arrest in the G0/G1 by schizandrin, a dibenzocyclooctadiene lignan isolated from Schisandra chinensis, on T47D human breast cancer cells. Phytother Res 24: 193-197, 2010.
24. Chuang JY, Chang WC and Hung JJ: Hydrogen peroxide induces Sp1 methylation and thereby suppresses cyclin B1 via recruitment of Suv39H1 and HDAC1 in cancer cells. Free Radic Biol Med 51: 2309-2318, 2011.
25. Gatta R and Mantovani R: NF-Y substitutes H2A-H2B on active cell-cycle promoters: recruitment of CoREST-KDM1 and fine-tuning of H3 methylations. Nucleic Acids Res 36: 6592-6607, 2008.
26. Martinou JC and Youle RJ: Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21: 92-101, 2011.
27. Rosser CJ, Gaar M and Porvasnik S: Molecular fingerprinting of radiation resistant tumors: can we apprehend and rehabilitate the suspects? BMC Cancer 9: 225, 2009.
28. Lucken-Ardjomande S and Martinou JC: Regulation of Bcl-2 proteins and of the permeability of the outer mitochondrial membrane. CR Biol 328: 616-631, 2005.
29. Oda E, Ohki R, Murasawa H, et al: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058, 2000.
30. Smith AJ, Dai H, Correia C, et al: Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells. J Biol Chem 286: 17682-17692, 2011.
31. Ploner C, Kofler R and Villunger A: Noxa: at the tip of the balance between life and death. Oncogene 27 (Suppl 1): S84-S92, 2008.
32. Shibue T, Takeda K, Oda E, et al: Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 17: 2233-2238, 2003.
33. Adams JM and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998.
34. Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
35. Malorni W, Giammarioli AM, Matarrese P, et al: Protection against apoptosis by monoamine oxidase A inhibitors. FEBS Lett 426: 155-159, 1998.
36. Singh MM, Manton CA, Bhat KP, et al: Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors. Neuro Oncol 13: 894-903, 2011.